Detail Information of Xenobiotics-driven Alterations in 3D Complexes
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0022 Transporter Info | ||||
Gene Name | SLC15A2 | ||||
Transporter Name | Peptide transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
Xenobiotic Name | Oxacillin Drug Info | ||||
Xenobiotic Type | Approved Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 6196 | ||||
Docking Score | -7.34 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C19H19N3O5S | ||||
Molecular Weight | 401.4 | ||||
Canonical SMILES |
CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O
|
||||
InChI |
InChI=1S/C19H19N3O5S/c1-9-11(12(21-27-9)10-7-5-4-6-8-10)15(23)20-13-16(24)22-14(18(25)26)19(2,3)28-17(13)22/h4-8,13-14,17H,1-3H3,(H,20,23)(H,25,26)/t13-,14+,17-/m1/s1
|
||||
InChIKey | UWYHMGVUTGAWSP-JKIFEVAISA-N | ||||
Pharmaceutical Properties | Xlogp | 2.4 | Rotatable Bond Count | 4 | |
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | ||
Xenobiotic Name | Valganciclovir Drug Info | ||||
Xenobiotic Type | Approved Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 135413535 | ||||
Docking Score | -7.331 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C14H22N6O5 | ||||
Molecular Weight | 354.36 | ||||
Canonical SMILES |
CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N
|
||||
InChI |
InChI=1S/C14H22N6O5/c1-7(2)9(15)13(23)24-4-8(3-21)25-6-20-5-17-10-11(20)18-14(16)19-12(10)22/h5,7-9,21H,3-4,6,15H2,1-2H3,(H3,16,18,19,22)/t8?,9-/m0/s1
|
||||
InChIKey | WPVFJKSGQUFQAP-GKAPJAKFSA-N | ||||
Pharmaceutical Properties | Xlogp | -1.5 | Rotatable Bond Count | 9 | |
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 8 | ||
Xenobiotic Name | Cefixime Drug Info | ||||
Xenobiotic Type | Approved Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 5362065 | ||||
Docking Score | -7.043 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C16H15N5O7S2 | ||||
Molecular Weight | 453.5 | ||||
Canonical SMILES |
C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O
|
||||
InChI |
InChI=1S/C16H15N5O7S2/c1-2-6-4-29-14-10(13(25)21(14)11(6)15(26)27)19-12(24)9(20-28-3-8(22)23)7-5-30-16(17)18-7/h2,5,10,14H,1,3-4H2,(H2,17,18)(H,19,24)(H,22,23)(H,26,27)/b20-9-/t10-,14-/m1/s1
|
||||
InChIKey | OKBVVJOGVLARMR-QSWIMTSFSA-N | ||||
Pharmaceutical Properties | Xlogp | -0.7 | Rotatable Bond Count | 8 | |
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 12 | ||
Pagination
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.